Vagus Super Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 2.55 Cr
as on 21-06-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.00 Cr
as on 21-06-2024
- Revenue -0.70%
(FY 2021)
- Profit 57.68%
(FY 2021)
- Ebitda 56.34%
(FY 2021)
- Net Worth 25.45%
(FY 2021)
- Total Assets 24.25%
(FY 2021)
About Vagus Super Speciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.55 Cr.
The company has closed loans amounting to ₹15.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Uma Kesaragere, Muniyappa Muniraj, and Venkatappa Narayanaswamy serve as directors at the Company.
- CIN/LLPIN
U85110KA2006PTC038997
- Company No.
038997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vagus Super Speciality Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatappa Narayanaswamy  | Managing Director | 17-Apr-2006 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uma Kesaragere | Director | 16-Nov-2016 | Current |
| Muniyappa Muniraj | Director | 29-Oct-2020 | Current |
Financial Performance of Vagus Super Speciality Hospital.
Vagus Super Speciality Hospital Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.7% decrease. The company also saw a substantial improvement in profitability, with a 57.68% increase in profit. The company's net worth Soared by an impressive increase of 25.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vagus Super Speciality Hospital?
In 2021, Vagus Super Speciality Hospital had a promoter holding of 45.00% and a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Narayanaswamy Super Speciality Hospitals Private LimitedActive 13 years 5 monthsUma Kesaragere and Venkatappa Narayanaswamy are mutual person
Genelon Institute Of Life Science Private LimitedActive 12 years 10 monthsMuniyappa Muniraj is a mutual person
Jeera Sannidhi Medical And Research Centre Private LimitedActive 5 years 4 monthsUma Kesaragere is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Jun 2008 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Vagus Super Speciality Hospital?
Vagus Super Speciality Hospital has a workforce of 13 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vagus Super Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vagus Super Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
